BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 18990758)

  • 21. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.
    Chang ET; Birmann BM; Kasperzyk JL; Conti DV; Kraft P; Ambinder RF; Zheng T; Mueller NE
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):976-86. PubMed ID: 19223558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample.
    Zhao ZZ; Nyholt DR; Le L; Thomas S; Engwerda C; Randall L; Treloar SA; Montgomery GW
    Hum Reprod; 2007 Sep; 22(9):2389-97. PubMed ID: 17595314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients.
    Azevedo ZM; Moore DB; Lima FC; Cardoso CC; Bougleux R; Matos GI; Luz RA; Xavier-Elsas P; Sampaio EP; Gaspar-Elsas MI; Moraes MO
    Hum Immunol; 2012 Jun; 73(6):661-7. PubMed ID: 22507624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
    Warzocha K; Ribeiro P; Bienvenu J; Roy P; Charlot C; Rigal D; Coiffier B; Salles G
    Blood; 1998 May; 91(10):3574-81. PubMed ID: 9572991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis.
    Sode J; Bank S; Vogel U; Andersen PS; Sørensen SB; Bojesen AB; Andersen MR; Brandslund I; Dessau RB; Hoffmann HJ; Glintborg B; Hetland ML; Locht H; Heegaard NH; Andersen V
    BMC Med Genet; 2018 Sep; 19(1):165. PubMed ID: 30208882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis.
    Alrashid MH; Al-Serri A; Alshemmari SH; Geo JA; Al-Bustan SA
    Cancer Biomark; 2021; 32(1):11-18. PubMed ID: 34024815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
    Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
    Nowak J; Kalinka-Warzocha E; Juszczynski P; Bilinski P; Mika-Witkowska R; Zajko M; Bienvenu J; Coiffier B; Salles G; Warzocha K
    Genes Chromosomes Cancer; 2007 May; 46(5):500-7. PubMed ID: 17311253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes.
    Zeggini E; Groves CJ; Parkinson JR; Halford S; Owen KR; Frayling TM; Walker M; Hitman GA; Levy JC; O'Rahilly S; Hattersley AT; McCarthy MI
    Diabetologia; 2005 Oct; 48(10):2013-7. PubMed ID: 16132956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Mehegan J; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1386-94. PubMed ID: 20080841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of tumor-necrosis factor-alpha - 308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells.
    Jevtovic-Stoimenov T; Kocic G; Pavlovic D; Macukanovic-Golubovic L; Marjanovic G; Djordjevic V; Tosić N; Pavlović S
    Leuk Lymphoma; 2008 Nov; 49(11):2163-9. PubMed ID: 19021060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haplotype analysis of a 100 kb region spanning TNF-LTA identifies a polymorphism in the LTA promoter region that is associated with atopic asthma susceptibility in Japan.
    Migita O; Noguchi E; Koga M; Jian Z; Shibasaki M; Migita T; Ito S; Ichikawa K; Matsui A; Arinami T
    Clin Exp Allergy; 2005 Jun; 35(6):790-6. PubMed ID: 15969671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
    Ye X; Zhao K; Wu C; Hu P; Fu H
    Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
    Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
    Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia.
    Wouters MM; Lambrechts D; Becker J; Cleynen I; Tack J; Vigo AG; Ruiz de León A; Urcelay E; Pérez de la Serna J; Rohof W; Annese V; Latiano A; Palmieri O; Mattheisen M; Mueller M; Lang H; Fumagalli U; Laghi L; Zaninotto G; Cuomo R; Sarnelli G; Nöthen MM; Vermeire S; Knapp M; Gockel I; Schumacher J; Boeckxstaens GE
    Gut; 2014 Sep; 63(9):1401-9. PubMed ID: 24259423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality.
    Song Z; Song Y; Yin J; Shen Y; Yao C; Sun Z; Jiang J; Zhu D; Zhang Y; Shen Q; Gao L; Tong C; Bai C
    PLoS One; 2012; 7(9):e46113. PubMed ID: 23029405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.
    He YQ; Zhu JH; Huang SY; Cui Z; He J; Jia WH
    Tumour Biol; 2014 Dec; 35(12):12509-17. PubMed ID: 25204673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
    Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
    Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.